Dermatology Times

🚨 BREAKING NEWS: A second study has confirmed initial reports of #benzene presence and formulation in #benzoylperoxide acne products—this time, with testing conducted at room temperature. Results demonstrated that 34% of 111 tested products, equivalent to 38 products, contained benzene levels above the FDA's 2 parts per million limit. "For colleagues with questions or concerns, I encourage them first to read carefully the primary research articles. Then, the single most immediate step they could take to mitigate concerns about using benzoyl peroxide products or patient fears is to encourage refrigeration of the medicine at all times, replace the medicine every ~ 12 weeks, and avoid storage in or near heat and sunlight," Christopher Bunick, MD, PhD, told Dermatology Times. https://lnkd.in/gyzjuScS

🖇READ MORE: A recent review highlighted the lack of diversity in clinical trials for HS, limiting understanding of treatment efficacy for SOC populations.

📚 STUDY FINDINGS: Bimekizumab achieved high efficacy in reducing symptoms among older patients with psoriasis, with more than half of patients experiencing complete skin clearance after 16 weeks of treatment. 🖇 Read more: https://lnkd.in/g9Fi3ePM

🎥 EXPERT INSIGHTS: Lead investigator of the BE BOLD study, Philip Mease, MD, spoke about the importance of head-to-head studies and how the results of BE BOLD could affect treatment guidelines.

💡 EXPERT INSIGHTS: Evan Rieder, MD, discusses the intersection between mental health and eczema, addressing burden of disease, and the role of an immersive experience in shedding light on the patient experience. 🖇 Read more: https://lnkd.in/g6giPTdB

📰 FROM OUR PUBLICATION: Attendees at September's Maui Derm NP+PA Fall 2024 Conference filled the presentation space for an acne and rosacea update, which was presented by Julie Harper, MD; Hilary Baldwin, MD; and James Del Rosso, DO. 🖇 Read more: https://lnkd.in/gk6it8md

📖 IN REVIEW: A review on alopecia areata in children and adolescents highlighted its profound psychosocial impact, including low self-esteem, social anxiety, and impaired quality of life. The findings emphasize the need for tailored interventions to address these emotional challenges. 🖇 Read more: https://lnkd.in/gr4TGD2B

📰 FROM OUR PUBLICATION: In a series of Dermatology Times Case-Based Roundtable events, 4 dermatologists led discussions for local colleagues to delve into complex cases of vitiligo. Andrew Alexis, MD, MPH, FAAD, hosted a discussion in New York, New York. 🖇 Read more: https://lnkd.in/gS_eMVB5

📹PATIENT PERSPECTIVES: Kristine Kucera, PA-C, MPAS, DHS, and Mickey Bryson, a patient with atopic dermatitis, provide valuable insights into empowering patients and reflecting on the impact of AD on quality of life. Watch now to elevate your understanding of atopic dermatitis care: https://ow.ly/Y93f50TJVaa

💡 INSIGHTS: A new study recently confirmed findings from earlier this year, showing significant benzene contamination in benzoyl peroxide products from major US retailers. To explore the clinical implications of these data, Dermatology Times spoke with Valisure's president and co-founder, David Light. 🎥 View the full interview now: https://lnkd.in/guCK76UH